Comment
. 1995 Jan 26;332(4):271; author reply 272-3.
Deferoxamine in thalassemia major
- PMID: 7808502
Item in Clipboard
Comment
Deferoxamine in thalassemia major
N Engl J Med.
.
No abstract available
Comment on
-
Survival in medically treated patients with homozygous beta-thalassemia.N Engl J Med. 1994 Sep 1;331(9):574-8. doi: 10.1056/NEJM199409013310903. N Engl J Med. 1994. PMID: 8047081
Similar articles
-
Deferoxamine in thalassemia major.N Engl J Med. 1995 Jan 26;332(4):270-1. N Engl J Med. 1995. PMID: 7808501 No abstract available.
-
Deferoxamine in thalassemia major.N Engl J Med. 1995 Jan 26;332(4):271-2; author reply 272-3. N Engl J Med. 1995. PMID: 7808503 No abstract available.
-
Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.Haematologica. 1993 May-Jun;78(3):183-4. Haematologica. 1993. PMID: 8375749
-
Iron chelating in thalassaemia with left ventricular dysfunction.Heart. 2006 Oct;92(10):1440. doi: 10.1136/hrt.2006.088377. Heart. 2006. PMID: 16973798 Free PMC article. No abstract available.
-
Long-term intravenous deferoxamine treatment for noncompliant transfusion-dependent beta-thalassemia patients.Isr J Med Sci. 1994 Aug;30(8):658-64. Isr J Med Sci. 1994. PMID: 8045754
Cited by
-
Hematopietic stem cell transplantation in thalassemia and related disorders.Mediterr J Hematol Infect Dis. 2009 Dec 3;1(1):e2009015. doi: 10.4084/MJHID.2009.015. Mediterr J Hematol Infect Dis. 2009. PMID: 21415993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources